Alterations of Zinc Transporter Proteins ZnT-1, ZnT-4 and ZnT-6 in Preclinical Alzheimer's Disease Brain

Overview

Journal Brain Pathol

Date 2009 Apr 18

PMID 19371353

Citations 48

Authors

Ganna Lyubartseva

Jennifer L Smith

William R Markesbery

Mark A Lovell

Affiliations

Soon will be listed here.

Abstract

Our previous studies demonstrate alterations of zinc (Zn) transporter proteins ZnT-1, ZnT-4 and ZnT-6 in vulnerable brain regions of subjects with mild cognitive impairment (MCI), and early and late stage Alzheimer's disease (AD), suggesting disruptions of Zn homeostasis may play a role in the pathogenesis of AD. A preclinical stage of AD (PCAD) has been described in which subjects show no overt clinical manifestations of AD, but demonstrate significant AD pathology at autopsy. To determine if alterations of ZnT proteins occur in PCAD, we measured ZnT-1, ZnT-4 and ZnT-6 in the hippocampus/parahippocampal gyrus (HPG) and cerebellum (CER) of seven PCAD subjects and seven age-matched normal control (NC) subjects using Western blot analysis and immunohistochemistry. Our results show a significant decrease (P < 0.05) of ZnT-1 in HPG of PCAD subjects, along with an increase of ZnT-4 in PCAD CER and ZnT-6 in PCAD HPG, but a significant decrease in PCAD CER compared to NC subjects. Confocal microscopy of representative sections of HPG shows altered ZnTs are associated with neurons immunopositive for MC-1, a monoclonal antibody that identifies neurons early in formation of neurofibrillary tangles. Overall, our results suggest that alterations in Zn transport proteins may contribute to the pathology observed in PCAD subjects before onset of clinical symptoms.

Citing Articles

SENP1 mediates zinc-induced ZnT6 deSUMOylation at Lys-409 involved in the regulation of zinc metabolism in Golgi apparatus.

Song C, Liu T, Hogstrand C, Zhong C, Zheng H, Sun L Cell Mol Life Sci. 2024; 81(1):422.

PMID: 39367979 PMC: 11455790. DOI: 10.1007/s00018-024-05452-4.

CRISPR/Cas9 Gene Editing: A Novel Approach Towards Alzheimer's Disease Treatment.

Tripathi S, Sharma Y, Rane R, Kumar D CNS Neurol Disord Drug Targets. 2024; 23(12):1405-1424.

PMID: 38716549 DOI: 10.2174/0118715273283786240408034408.

Structural insights into the calcium-coupled zinc export of human ZnT1.

Sun C, He B, Gao Y, Wang X, Liu X, Sun L Sci Adv. 2024; 10(17):eadk5128.

PMID: 38669333 PMC: 11051671. DOI: 10.1126/sciadv.adk5128.

Long-term suboptimal dietary trace element supply does not affect trace element homeostasis in murine cerebellum.

Friese S, Ranzini G, Tuchtenhagen M, Lossow K, Hertel B, Pohl G Metallomics. 2024; 16(2).

PMID: 38299785 PMC: 10873500. DOI: 10.1093/mtomcs/mfae003.

Cellular zinc metabolism and zinc signaling: from biological functions to diseases and therapeutic targets.

Chen B, Yu P, Chan W, Xie F, Zhang Y, Liang L Signal Transduct Target Ther. 2024; 9(1):6.

PMID: 38169461 PMC: 10761908. DOI: 10.1038/s41392-023-01679-y.

References

Fagan A, Csernansky C, Morris J, Holtzman D . The search for antecedent biomarkers of Alzheimer's disease. J Alzheimers Dis. 2006; 8(4):347-58. DOI: 10.3233/jad-2005-8404. View

Lovell M, Smith J, Xiong S, Markesbery W . Alterations in zinc transporter protein-1 (ZnT-1) in the brain of subjects with mild cognitive impairment, early, and late-stage Alzheimer's disease. Neurotox Res. 2005; 7(4):265-71. DOI: 10.1007/BF03033884. View

Assaf S, Chung S . Release of endogenous Zn2+ from brain tissue during activity. Nature. 1984; 308(5961):734-6. DOI: 10.1038/308734a0. View

Dufner-Beattie J, Langmade S, Wang F, Eide D, Andrews G . Structure, function, and regulation of a subfamily of mouse zinc transporter genes. J Biol Chem. 2003; 278(50):50142-50. DOI: 10.1074/jbc.M304163200. View

Frederickson C, Koh J, Bush A . The neurobiology of zinc in health and disease. Nat Rev Neurosci. 2005; 6(6):449-62. DOI: 10.1038/nrn1671. View

Religa D, Strozyk D, Cherny R, Volitakis I, Haroutunian V, Winblad B . Elevated cortical zinc in Alzheimer disease. Neurology. 2006; 67(1):69-75. DOI: 10.1212/01.wnl.0000223644.08653.b5. View

Sekler I, Moran A, Hershfinkel M, Dori A, Margulis A, Birenzweig N . Distribution of the zinc transporter ZnT-1 in comparison with chelatable zinc in the mouse brain. J Comp Neurol. 2002; 447(3):201-9. DOI: 10.1002/cne.10224. View

Brock B, Basha R, DiPalma K, Anderson A, Harry G, Rice D . Co-localization and distribution of cerebral APP and SP1 and its relationship to amyloidogenesis. J Alzheimers Dis. 2008; 13(1):71-80. PMC: 5862394. DOI: 10.3233/jad-2008-13108. View

Wilquet V, De Strooper B . Amyloid-beta precursor protein processing in neurodegeneration. Curr Opin Neurobiol. 2004; 14(5):582-8. DOI: 10.1016/j.conb.2004.08.001. View

10.

Xie Z, Tanzi R . Alzheimer's disease and post-operative cognitive dysfunction. Exp Gerontol. 2006; 41(4):346-59. DOI: 10.1016/j.exger.2006.01.014. View

11.

Cornett C, Markesbery W, Ehmann W . Imbalances of trace elements related to oxidative damage in Alzheimer's disease brain. Neurotoxicology. 1998; 19(3):339-45. View

12.

Braak H, Braak E . Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991; 82(4):239-59. DOI: 10.1007/BF00308809. View

13.

Galvin J, Powlishta K, Wilkins K, McKeel Jr D, Xiong C, Grant E . Predictors of preclinical Alzheimer disease and dementia: a clinicopathologic study. Arch Neurol. 2005; 62(5):758-65. DOI: 10.1001/archneur.62.5.758. View

14.

Markesbery W . Oxidative stress hypothesis in Alzheimer's disease. Free Radic Biol Med. 1997; 23(1):134-47. DOI: 10.1016/s0891-5849(96)00629-6. View

15.

Lovell M, Smith J, Markesbery W . Elevated zinc transporter-6 in mild cognitive impairment, Alzheimer disease, and pick disease. J Neuropathol Exp Neurol. 2006; 65(5):489-98. DOI: 10.1097/01.jnen.0000229237.98124.91. View

16.

Morris J, Price J . Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease. J Mol Neurosci. 2002; 17(2):101-18. DOI: 10.1385/jmn:17:2:101. View

17.

Zhang L, Wang X, Zheng Z, Ren H, Stoltenberg M, Danscher G . Altered expression and distribution of zinc transporters in APP/PS1 transgenic mouse brain. Neurobiol Aging. 2008; 31(1):74-87. DOI: 10.1016/j.neurobiolaging.2008.02.018. View

18.

Hebert L, Scherr P, Bienias J, Bennett D, Evans D . Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch Neurol. 2003; 60(8):1119-22. DOI: 10.1001/archneur.60.8.1119. View

19.

Cousins R, Liuzzi J, Lichten L . Mammalian zinc transport, trafficking, and signals. J Biol Chem. 2006; 281(34):24085-9. DOI: 10.1074/jbc.R600011200. View

20.

Lovell M, ROBERTSON J, Teesdale W, Campbell J, Markesbery W . Copper, iron and zinc in Alzheimer's disease senile plaques. J Neurol Sci. 1998; 158(1):47-52. DOI: 10.1016/s0022-510x(98)00092-6. View